Analyst · Unicycive Therapeutics, Inc. (UNCY) | Ratings, Price Targets & Consensus

Analyst Consensus

Buy8 analysts

Buy

Updated Jul 13, 2026

Total Analysts8

Buy

8

Ratings

Updated Jul 13, 2026

Overall Rating

C

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$5.09

DCF Value-96.45%

$0.18

Potential downside vs current price

Analyst Consensus

Buy8 analysts

Buy

Updated Jul 13, 2026

Total Analysts8

Buy

8

Ratings

Updated Jul 13, 2026

Overall Rating

C

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$5.09

DCF Value-96.45%

$0.18

Potential downside vs current price